Digital B2B platforms for pharmaceutical procurement are projected to handle over $280B in annual transaction value by 2028, up from $94B in 2023.
Market Segments
The market divides into three primary segments: API and raw material procurement platforms, finished goods trading marketplaces, and equipment and services directories.
Regulatory Considerations
Platform operators must navigate GMP documentation requirements and country-specific import/export licensing, creating a high barrier to entry that favors established players.